Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type i assessed by high-resolution pQCT

Journal of Bone and Mineral Research

Volumn 27, Issue 6, 2012, Pages 1405-1412

  Folkestad, Lars ^a,b,c   Hald, Jannie Dahl ^d   Hansen, Stinus ^a,c   Gram, Jeppe ^b   Langdahl, Bente ^d   Abrahamsen, Bo ^c,e   Brixen, Kim ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ADULT; BONE DENSITOMETRY; HR pQCT; MICROARCHITECTURE; OSTEOGENESIS IMPERFECTA

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENDER; GREATER TROCHANTER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIP; HUMAN; HYPOTHESIS; LUMBAR SPINE; MALE; OSTEOGENESIS IMPERFECTA; OSTEOGENESIS IMPERFECTA TYPE 1; QUANTITATIVE ANALYSIS; RADIUS; TIBIA; TRABECULAR BONE;

ADULT; AGED; AREA UNDER CURVE; BONE DENSITY; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OSTEOGENESIS IMPERFECTA; RADIUS; SPINAL FRACTURES; TIBIA; TIBIAL FRACTURES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84861316084     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1592     Document Type: Article

References (38)

1. Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM., Classification of Osteogenesis Imperfecta revisited. Eur J Med Genet. 2010; 53 (1): 1-5.
2. Sillence D, Senn D, Danks D., Genetic heterogeneity in OI. J Med Genet. 1979; 16: 101-16.
3. Ben Amor IM, Glorieux FH, Rauch F., Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011; 2011: 540178.
4. Forlino A, Cabral WA, Barnes AM, Marini JC., New perspectives on osteogenesis imperfecta. Nature reviews. Endocrinology. 2011; 7 (9): 540-57.
5. Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, Dalton A., Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat. 2006; 27 (7): 716.
6. Rauch F, Glorieux FH., Osteogenesis imperfecta. Lancet. 2004; 363 (9418): 1377-185.
7. Andersen PE Jr, Hauge M., Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clin Genet. 1989; 36 (4): 250-5.
8. Bouxsein ML., Determinants of skeletal fragility. Best Pract Res Clin Rheumatol. 2005; 19 (6): 897-911.
9. Wenstrup RJ, Willing MC, Starman BJ, Byers PH., Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet. 1990; 46 (5): 975-82.
10. Davie MW, Haddaway MJ., Bone mineral content and density in healthy subjects and in osteogenesis imperfecta. Arch Dis Child. 1994; 70 (4): 331-4.
11. Gelse K, Poschl E, Aigner T., Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003; 55 (12): 1531-46.
12. Shapiro JR, McCarthy EF, Rossiter K, Ernest K, Gelman R, Fedarko N, Santiago HT, Bober M., The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta. Calcif Tissue Int. 2003; 72 (2): 103-12.
13. Bishop N., Characterising and treating osteogenesis imperfecta. Early Hum Dev. 2010; 86 (11): 743-6.
14. Rauch F, Travers R, Plotkin H, Glorieux FH., The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002; 110 (9): 1293-9.
15. Nishiyama KK, Boyd SK., In vivo assessment of trabecular and cortical bone microstructure. Clin Calcium. 2011; 21 (7): 1011-9.
16. Cepollaro C, Gonnelli S, Pondrelli C, Montagnani A, Martini S, Bruni D, Gennari C., Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters. Calcif Tissue Int. 1999; 65 (2): 129-32.
17. Wekre LL, Eriksen EF, Falch JA., Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta. Arch Osteoporos. 2011; 6 (1-2): 31-8.
18. Boutroy S, Bouxsein ML, Munoz F, Delmas PD., In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005; 90 (12): 6508-15.
19. Buie HR, Campbell GM, Klinck RJ, MacNeil JA, Boyd SK., Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone. 2007; 41 (4): 505-15.
20. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S., Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res. 2010; 25 (5): 983-93.
21. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK., Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res. 2010; 25 (4): 882-90.
22. Hansen S, Beck Jensen JE, Rasmussen L, Hauge EM, Brixen K., Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. J Bone Miner Res. 2010; 25 (9): 1941-7.
23. Gatti D, Colapietro F, Fracassi E, Sartori E, Antoniazzi F, Braga V, Rossini M, Adami S., The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. J Clin Densitom. 2003; 6 (2): 173-7.
24. Rauch F, Land C, Cornibert S, Schoenau E, Glorieux FH., High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta. Bone. 2005; 37 (5): 634-41.
25. Epstein S., Is cortical bone hip? What determines cortical bone properties ? Bone. 2007; 41 (1 Suppl 1): S3-8.
26. Bousson V, Bergot C, Meunier A, Barbot F, Parlier-Cuau C, Laval-Jeantet AM, Laredo JD., CT of the middiaphyseal femur: cortical bone mineral density and relation to porosity. Radiology. 2000; 217 (1): 179-87.
27. Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S., Bone turnover markers in patients with osteogenesis imperfecta. Bone. 2004; 34 (6): 1013-6.
28. McCarthy EF, Earnest K, Rossiter K, Shapiro J., Bone histomorphometry in adults with type IA osteogenesis imperfecta. Clin Orthop Relat Res. 1997; (336): 254-62.
29. Marini JC., Osteogenesis imperfecta. In:, Rosen C, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Vol. 7. Washington, DC: American Society for Bone and Mineral Research (ASBMR); 2008. p. 446-50.
30. Nielsen TL, Wraae K, Brixen K, Hermann AP, Andersen M, Hagen C., Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study. Int J Obes (Lond). 2006; 30 (5): 805-15.
31. Meyer HE, Berntsen GK, Sogaard AJ, Langhammer A, Schei B, Fonnebo V, Forsmo S, Tell GS., Higher bone mineral density in rural compared with urban dwellers: the NOREPOS study. Am J Epidemiol. 2004; 160 (11): 1039-46.
32. Gardsell P, Johnell O, Nilsson BE, Sernbo I., Bone mass in an urban and a rural population: a comparative, population-based study in southern Sweden. J Bone Miner Res. 1991; 6 (1): 67-75.
33. El Hage R., Geometric indices of hip bone strength in obese, overweight, and normal-weight adolescent boys. Osteoporos Int. Epub 2011 Sep 1.
34. Kaptoge S, Jakes RW, Dalzell N, Wareham N, Khaw KT, Loveridge N, Beck TJ, Reeve J., Effects of physical activity on evolution of proximal femur structure in a younger elderly population. Bone. 2007; 40 (2): 506-15.
35. Szulc P, Debiesse E, Boutroy S, Vilauphiou N, Chapurlat R., Poor trabecular microarchitecture in male current smokers: the cross-sectional STRAMBO study. Calcif Tissue Int. 2011; 89 (4): 303-11.
36. Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tato L., Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res. 2003; 18 (1): 126-30.
37. Chevrel G, Schott AM, Fontanges E, Charrin JE, Lina-Granade G, Duboeuf F, Garnero P, Arlot M, Raynal C, Meunier PJ., Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. J Bone Miner Res. 2006; 21 (2): 300-6.
38. Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C., Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta. Calcif Tissue Int. 2010; 87 (2): 120-9.